Fortunately, we found three potential binding sites on PINK1 gene promoter for NFIB (Fig. 4B) (Khan et al., 2018; Messeguer et al., 2002), and bioinformatics analysis revealed that PINK1 was enriched in focal adhesion and pathways in cancer (Table S5). This evidence concerns the gene NFIB and cancer.